Search IPOs
SMT · NSE · Medical Technology & Devices
Sahajanand Medical Technologies IPO opens for subscription from 15 Oct 2026 to 19 Oct 2026. The Mainboard IPO has a price band of ₹327-₹344 , with a face value of ₹1 per share and lot size of 43 shares . The IPO will list on 23 Oct 2026 on NSE.
Sahajanand Medical Technologies IPO tentative timeline covering IPO opening, closing, basis of allotment, refunds, demat credit, and listing dates.
| Event | Date |
|---|---|
| IPO Open Date | 15 Oct 2026 |
| IPO Close Date | 19 Oct 2026 |
| Basis of Allotment | 21 Oct 2026 |
| Initiation of Refunds | 22 Oct 2026 |
| Credit of Shares to Demat | 22 Oct 2026 |
| Listing Date | 23 Oct 2026 |
Issue Size
13,822,116 shares
(aggregating up to ₹475.00 Cr)
Issue Price
₹327 – ₹344
Face Value
₹1/share
Market Lot
43 shares
Retail Min Investment
₹14,792
Listing At
NSE
Sale Type
offer for sale
Fresh Issue
[.]
Offer for Sale
13,822,116 shares
(aggregating up to ₹475 Cr)
Issue Type
book building
Open Date
15 Oct
Close Date
19 Oct
Allotment
21 Oct
Listing
23 Oct
Last updated: 33 minutes ago
| Date | IPO Issue Price (₹) | GMP (₹) | Est. Listing Price (₹) | Est. Profit Amount (₹) | Est. Profit % | Last Updated |
|---|---|---|---|---|---|---|
| 19 Oct 2026 Latest | ₹344 | ₹15 | ₹359 | ₹15 |
4.36%
|
1:30 PM |
| 19 Oct 2026 | ₹344 | ₹26 | ₹370 | ₹26 |
7.56%
|
1:00 PM |
Showing the 2 most recent GMP entries.
Sahajanand Medical Technologies IPO GMP today & full historyLatest snapshot: 19 Oct 2026
| Category | Subscribed (x) |
|---|---|
| QIB | 1.59x |
| NII | 3.79x |
| bNII (bids above ₹10L) | 3.9x |
| sNII (bids below ₹10L) | 3.57x |
| Retail Investors | 1.66x |
| Employees | 0.25x |
| Total | 2.05x |
Showing the latest subscription snapshot.
View full subscription historyBhargav Dhirajlal Kotadia, Dhirajlal Vallabhbhai Kotadia, Priyanka Dhirajlal Cohen, Shree Hari Trust
New to lot sizes and investment limits? Read our guide on IPO lot size and minimum investment.
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 43 | ₹14,792 |
| Retail (Max) | 13 | 559 | ₹192,296 |
| S-HNI (Min) | 14 | 602 | ₹207,088 |
| S-HNI (Max) | 67 | 2,881 | ₹991,064 |
| B-HNI (Min) | 68 | 2,924 | ₹1,005,856 |
| Application Category | Maximum Bidding Limits | Bidding at Cut-off Price Allowed |
|---|---|---|
| Only employee | 1 | No |
Want to understand how IPO shares are divided between investor categories? Read our guide on IPO reservation structure.
| Category | Shares Offered |
|---|---|
| QIB Shares Offered | 6,786,058 (49.10%) |
|
•
Anchor Investor Shares Offered
|
4,071,634 (29.46%) |
|
•
QIB (Ex. Anchor) Shares Offered
|
2,714,424 (19.64%) |
| NII (HNI) Shares Offered | 2,035,817 (14.73%) |
|
•
bNII > ₹10L
|
1,357,212 (9.82%) |
|
•
sNII < ₹10L
|
678,605 (4.91%) |
| Retail Shares Offered | 4,750,241 (34.37%) |
| Employees Shares Offered | 250,000 (1.81%) |
| Total Shares Offered | 13,822,116 (100.01%) |
Sahajanand Medical Technologies Limited was founded in 2001 and is based in Surat, Gujarat. It works in the medical devices sector, developing and manufacturing cardiovascular devices.
The company is a research and development-focused maker of Class III and Class C/D medical devices, with an emphasis on vascular intervention and structural heart products. Its portfolio includes drug eluting stents, which it has been known for in the Indian market. Major shareholders include Samara Capital Markets Holding Limited, Kotak Pre-IPO Opportunities Fund, Plutus Wealth Management LLP and Ashish Kacholia.
Revenue from operations rose 13.67% to Rs 1,024.88 crore in FY25, as per the DRHP filed on 25 July 2025. The IPO is a mainboard book-built issue proposed to be listed on the BSE and NSE, structured entirely as an offer for sale of up to 2,76,44,231 equity shares of face value Re 1 each, with no fresh issue. The selling shareholders are Shree Hari Trust, Dhirajkumar Savjibhai Vasoya, Samara Capital Markets Holding Limited, Kotak Pre-IPO Opportunities Fund and NHPEA Sparkle Holding B.V. The price band has not been announced. As the offer is entirely an offer for sale, the company will not receive any proceeds from the issue.
Standalone · ₹ in Crores
| Particulars | FY Mar 2025 | FY Mar 2026 | FY Jun 2026 |
|---|---|---|---|
| Total Revenue | 1,035.96 | 1,218.73 | 354.33 |
| Profit After Tax (PAT) | 25.15 | 69.08 | 15.09 |
| EBITDA | 128.02 | 170.66 | 48.58 |
| Total Assets | 1,094.9 | 1,276.43 | 1,309 |
| Net Worth | 545.23 | 616.05 | 631.72 |
| Reserves & Surplus | 580.71 | 692.48 | 706.86 |
| Total Borrowing | 224.96 | 269.53 | 320.63 |
Revenue & Profit Trend
Key ratios per fiscal period
| Particulars | Mar 2026 | Jun 2026 |
|---|---|---|
| RoE Return on Equity Shows how much profit the company makes on the money shareholders have put in. 15% to 20% is healthy in most industries. | 10.35% | 2.07% |
| RoCE Return on Capital Employed Shows the profit earned on all the money used, shareholder funds plus loans. Matters most for factory and infrastructure heavy companies. | 11.57% | 3.16% |
| RoNW Return on Net Worth Shows the profit earned on the company's own net worth. Steady or rising over 3 years is a good sign. | 10.6% | 2.31% |
| PAT Margin Profit After Tax Margin Out of every ₹100 of sales, how much the company keeps after paying all costs, loan interest and tax. | 5.71% | 4.29% |
| EBITDA Margin Earnings Before Interest, Tax, Depreciation and Amortisation Margin Profit from the main business as a share of sales, before loan interest and tax. Compare it with other companies in the same industry. | 14.1% | 13.81% |
| Debt / Equity Debt to Equity How much the company has borrowed against what shareholders own. Above 1x means the loans are bigger than shareholder funds. | 0.27x | 0.33x |
| P/BV Price to Book Value Tells you if the IPO price is above what the company actually owns. 1x to 3x is usually seen as reasonable. | 5.48x | - |
Issue-level · at the upper price band
| Particulars | Pre-IPO | Post-IPO |
|---|---|---|
| EPS Earnings Per Share Profit the company earns on each share. Post-IPO EPS is usually lower because the issue adds new shares. | ₹6.8 | ₹5.94 |
| P/E Price to Earnings Tells you if the IPO price is fair for what the company earns. Compare it with listed companies in the same sector. | 50.59x | 57.91x |
| Market Cap Market Capitalisation What the whole company is valued at, at the upper price band. Post-IPO counts the new shares the issue creates. | ₹3,497 Cr | ₹3,497 Cr |
The basis of allotment for Sahajanand Medical Technologies IPO is scheduled for 21 Oct 2026. You can check your allotment status using your PAN number or application number on the MUFG Intime India Pvt.Ltd portal or BSE.
The Sahajanand Medical Technologies IPO is expected to open in Oct 2026, subject to SEBI approval. Final dates will be updated once announced officially.
The price band for Sahajanand Medical Technologies IPO is ₹327.00 - ₹344.00 per share.
As per market sources, Sahajanand Medical Technologies IPO GMP is currently ₹15.00. GMP is tracked daily in the grey market. GMP indicates unofficial demand but does not guarantee listing gains.
The subscription status for Sahajanand Medical Technologies IPO stands at 2.05x overall.
The listing date for Sahajanand Medical Technologies IPO is 23 Oct 2026.
No comments yet. Be the first to comment!
